These two authors contributed equally to this work.
Steatohepatitis/Metabolic Liver Disease
Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia
Article first published online: 28 JAN 2014
© 2014 by the American Association for the Study of Liver Diseases
Volume 59, Issue 3, pages 858–869, March 2014
How to Cite
Jha, P., Claudel, T., Baghdasaryan, A., Mueller, M., Halilbasic, E., Das, S. K., Lass, A., Zimmermann, R., Zechner, R., Hoefler, G. and Trauner, M. (2014), Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia. Hepatology, 59: 858–869. doi: 10.1002/hep.26732
Potential conflict of interest: Prof. Trauner consults for, is on the speakers' bureau for, and received grants from Falk. He is on the speakers' bureau for and received grants from MSD. He consults for Phenex. He is on the speakers' bureau for Gilead and Roche. He received grants from Intercept.
Supported by grants F3008 (to MT) and F3002 (R. Zechner) from the Austrian Science Foundation and European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement HEALTH-F2-2009-241762 for the project FLIP (to MT). P. Jha was also supported by the PhD program of the Medical University of Graz.
- Issue published online: 25 FEB 2014
- Article first published online: 28 JAN 2014
- Accepted manuscript online: 3 SEP 2013 11:45AM EST
- Manuscript Accepted: 29 AUG 2013
- Manuscript Received: 7 MAR 2013
- 25Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha — and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus. Proc Natl Acad Sci U S A 2001;98:2323-2328., , , .